The rs12975333 variant in the miR-125a and breast cancer risk in Germany, Italy, Australia and Spain

Journal of Medical Genetics

Volumn 48, Issue 10, 2011, Pages 703-704

  Peterlongo, Paolo ^a,b   Caleca, Laura ^b   Cattaneo, Elisa ^b,c   Ravagnani, Fernando ^b   Bianchi, Tiziana ^d   Galastri, Laura ^d   Bernard, Loris ^e   Ficarazzi, Filomena ^f   Dall'olio, Valentina ^f   Marme, Frederik ^g,h   Langheinz, Anne ^g,i   Sohn, Christoph ^g   Burwinkel, Barbara ^g,i   Giles, Graham G ^j   Baglietto, Laura ^j   Severi, Gianluca ^j   Odefrey, Fabrice A ^k   Southey, Melissa C ^k   Osorio, Ana ^l,m   Fernández, Fernando ^l   Alonso, Maria Rosario ^l   Benítez, Javier ^l,m   Barile, Monica ^e   Peissel, Bernard ^b   Manoukian, Siranoush ^b   Radice, Paolo ^a,b   more..

^a FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d Associazione Volontari Italiani Sangue Comunale   (Italy)

^e EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^f IFOM IEO Campus   (Italy)

^g UNIVERSITY OF HEIDELBERG   (Germany)

^h National Center for Tumor disease NCT   (Germany)

ⁱ GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^j CANCER EPIDEMIOLOGY CENTRE   (Australia)

^k UNIVERSITY OF MELBOURNE   (Australia)

^l Centro Nacional de Investigaciones Oncológicas   (Spain)

^m CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; MICRORNA; MICRORNA 125A; UNCLASSIFIED DRUG;

ARTICLE; AUSTRALIA; BLOOD DONOR; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GERM LINE; GERMANY; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; SEX RATIO; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN;

AUSTRALIA; BREAST NEOPLASMS; CASE-CONTROL STUDIES; EUROPE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; MICRORNAS;

EID: 80955159785     PISSN: 00222593     EISSN: 14686244     Source Type: Journal    
DOI: 10.1136/jmedgenet-2011-100103     Document Type: Article

References (9)

1. Duan R, Pak C, Jin P. Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA. Hum Mol Genet 2007;16:1124-31.
2. Li W, Duan R, Kooy F, et al. Germline mutation of microRNA-125a is associated with breast cancer. J Med Genet 2009;46:358-60.
3. Yang R, Dick M, Marme F, et al. Genetic variants within miR-126 and miR-335 are not associated with breast cancer risk. Breast Cancer Res Treat 2011;127: 549-54.
4. Catucci I, Verderio P, Pizzamiglio S, et al. SNPs in ultraconserved elements and familial breast cancer risk. Carcinogenesis 2009;30:544-5.
5. Giles GG, English DR. The Melbourne Collaborative Cohort Study. IARC Sci Publ 2002;156:69-70.
6. Muiños-Gimeno M, Montfort M, Bayés M, et al. Design and evaluation of a panel of single-nucleotide polymorphisms in microRNA genomic regions for association studies in human disease. Eur J Hum Genet 2010;18:218-26.
7. Hansen T, Olsen L, Lindow M, et al. Brain expressed microRNAs implicated in schizophrenia etiology. PLoS One 2007;2:e873.
8. Kontorovich T, Levy A, Korostishevsky M, et al. Single nucleotide polymorphisms in miRNA binding sites and miRNA genes as breast/ovarian cancer risk modifiers in Jewish high-risk women. Int J Cancer 2010;127:589-97.
9. O'Day E, Lal A. MicroRNAs and their target gene networks in breast cancer. Breast Cancer Res 2010;12:201-10.